The FDA’s indefensible approval of the Pfizer shot
From Horowitz
Stop the tape! Walensky now concedes the following:
There is zero justification to mandate the vaccine given that it doesn’t stop infection and transmission.
Even the personal protection from serious illness wanes after about six months or so and increasingly so for those most vulnerable to the virus who need the protection the most.
The vaccine efficacy wanes both over time and with mutant strains that will likely continue.
In a stunning admission, she says that reports from Israel seem to “suggest increased risk of severe disease amongst those vaccinated early.” This could indicate some degree of antibody dependent disease enhancement. After all, if the immunity is waning, then there is always a concern that the antibodies are strong enough to bind but not strong enough to block, which creates a more dangerous conduit for the virus into the cells, which is what people like mRNA vaccine inventor Dr. Robert Malone have been warning about. The FDA itself conceded in its memorandum (p.52) on the EUA approval of the shots, “Risk of vaccine-enhanced disease over time, potentially associated with waning immunity, remains unknown and needs to be evaluated further in ongoing clinical trials.”
Yet what is Walensky’s solution? To exacerbate this cycle and give yet another round of shots to everyone. Not only will this cause needless death and injury without long-term protection, but it will likely enhance viral immune escape even more. A pre-print study from Spanish researchers found that the antibody levels produced by booster shots to the Alpha variant seemed to net decreasing results. “Our results with the Alpha variant suggest that 3rd doses of present vaxes to the general population might not be the best approach to increase the immunity to the emerging VOCs,” gently concluded the authors. However, if these boosters are going to produce half-baked levels from the get-go, not only will the efficacy wane quicker (after users suffer all the side effects), but the risk for antibody dependent disease enhancement grows more alarming.